Bioxyne Limited

ASX (AUD): Bioxyne Limited (BXN)

Last Price

0.018

Today's Change

+0.004 (28.57%)

Day's Change

0.015 - 0.018

Trading Volume

11,733,536

Profile
BXN

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Consumer Defensive - Consumer Defensive Consumer Defensive - Consumer Defensive

Industry: 

CEO:  Mr. Samuel Watson Mr. Samuel Watson

Full Time Employees:  16 16

IPO Date:  2000-12-13 2000-12-13

CIK: 

ISIN:  AU000000BXN6 AU000000BXN6

CUSIP:  Q77474122 Q77474122

Beta:  0.78 0.78

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

Bioxyne Limited, a life sciences and health products company, researches, develops, markets, and distributes dietary supplement and beauty products. It perates in two segments, Wholesale Sales and Direct Sales. The company engages in developing various functional foods and beauty products. Its products portfolio includes Progastrim for Gut and Immune Health; Progastrim plus Vitamin C for cold symptoms; and proTract for atopic dermatitis (eczema) for infants. The company provides its products online, as well as through wholesale and direct sales in the United States and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.

Address

50 Clarence Street,
Sydney, NSW 2000, AU

61 2 9078 8180

http://www.bioxyne.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment